Integer Holdings Corporation $ITGR Stock Holdings Reduced by Cooke & Bieler LP

Key Points

• Cooke & Bieler LP reduced its Integer Holdings stake by 22.3% in the third quarter, selling 78,722 shares and retaining 274,743 shares valued at approximately $34.7 million. Institutional investors collectively own 99.29% of the company.
• Analyst sentiment is largely cautious: Integer has a consensus “Hold” rating from MarketBeat, with 13 Hold ratings and one Buy rating and an average price target of $109.86.
• Integer reported quarterly EPS of $1.60, beating estimates of $1.38, while revenue reached $464.11 million versus expectations of $451.07 million. The stock opened at $126.73, near its 12-month high of $126.83, while insiders sold $5.17 million of shares over the past 90 days.

Cooke & Bieler LP decreased its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 22.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 274,743 shares of the medical equipment provider's stock after selling 78,722 shares during the quarter. Cooke & Bieler LP owned 0.81% of Integer worth $34,714,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in Integer during the 2nd quarter worth approximately $29,000. EverSource Wealth Advisors LLC lifted its holdings in Integer by 48.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider's stock worth $32,000 after buying an additional 117 shares in the last quarter. Fortitude Family Office LLC lifted its holdings in Integer by 987.2% during the 3rd quarter. Fortitude Family Office LLC now owns 424 shares of the medical equipment provider's stock worth $54,000 after buying an additional 385 shares in the last quarter. Harbor Investment Advisory LLC purchased a new position in Integer in the 2nd quarter valued at approximately $42,000. Finally, Farther Finance Advisors LLC boosted its position in Integer by 64.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 490 shares of the medical equipment provider's stock valued at $62,000 after buying an additional 192 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Analysts Set New Price Targets

Several research firms have commented on ITGR. HC Wainwright restated a "buy" rating on shares of Integer in a research note on Friday, July 24th. KeyCorp cut Integer from an "overweight" rating to a "sector weight" rating in a research note on Monday, August 3rd. Wells Fargo & Company increased their price objective on Integer from $84.00 to $127.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 4th. Citigroup lifted their target price on Integer from $92.00 to $96.00 and gave the company a "neutral" rating in a report on Wednesday, July 8th. Finally, Benchmark cut Integer from a "buy" rating to a "hold" rating in a research note on Thursday, August 13th. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company's stock. According to data from MarketBeat, Integer currently has a consensus rating of "Hold" and an average price target of $109.86.

Insider Transactions at Integer

In other news, insider Kirk K. Thor sold 11,767 shares of the stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $126.23, for a total value of $1,485,348.41. Following the transaction, the insider owned 7,153 shares in the company, valued at approximately $902,923.19. This represents a 62.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Andrew Senn sold 9,408 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total value of $1,188,230.40. Following the completion of the transaction, the insider owned 5,405 shares in the company, valued at approximately $682,651.50. The trade was a 63.51% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 40,948 shares of company stock valued at $5,169,920 over the last ninety days. 1.10% of the stock is owned by company insiders.

Integer Price Performance

Integer stock opened at $126.73 on Thursday. The stock has a market cap of $4.31 billion, a P/E ratio of 34.63, a price-to-earnings-growth ratio of 2.41 and a beta of 0.58. The company has a fifty day simple moving average of $126.06 and a 200-day simple moving average of $105.41. Integer Holdings Corporation has a 12-month low of $62.00 and a 12-month high of $126.83. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping analysts' consensus estimates of $1.38 by $0.22. The firm had revenue of $464.11 million during the quarter, compared to the consensus estimate of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company's revenue was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.55 earnings per share. Equities analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation NYSE: ITGR is a global medical device and advanced energy technology company. It partners with original equipment manufacturers to design and manufacture components, subassemblies and finished products used in minimally invasive and implantable medical devices.

Its medical technologies include batteries and power systems for pacemakers, implantable cardioverter-defibrillators, neurostimulators and drug-delivery systems, as well as catheter and guidewire components, coated wire, electrodes and other products used in cardiovascular, neuromodulation and other medical applications.

Integer also develops specialty batteries and power solutions for markets such as energy, aerospace and defense.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.